More recently, (11C)UCB-J PET has been employed to study SV2A levels in aging [44], idiopathic PD [58,191,192], PSP and CBS [193], as well as across the cognitive spectrum in AD, from preclinical and MCI to advanced clinical dementia [62,194]. This evidence concerns the gene SV2A and supranuclear palsy, progressive, 1.